Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Immunogenicity, reactogenicity and safety study of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy Taiwanese infants who received hepatitis B immunoglobulin after birth.
Rotavirus Vaccine
RTX114351
NCT01198769
Infections, Rotavirus
Phase 4
 
September 2015

Powered by ideaPoint, Inc.